Works matching IS 00126667 AND DT 2021 AND VI 81 AND IP 15

Results: 14

Finerenone: First Approval.

Published in:

Drugs, 2021, v. 81, n. 15, p. 1787, doi. 10.1007/s40265-021-01599-7

By:

Frampton, James E.

Publication type:

Article

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin.

Published in:

Drugs, 2021, v. 81, n. 15, p. 1703, doi. 10.1007/s40265-021-01611-0

By:

Hoenigl, Martin;
Sprute, Rosanne;
Egger, Matthias;
Arastehfar, Amir;
Cornely, Oliver A.;
Krause, Robert;
Lass-Flörl, Cornelia;
Prattes, Juergen;
Spec, Andrej;
Thompson III, George R.;
Wiederhold, Nathan;
Jenks, Jeffrey D.

Publication type:

Article

Bimekizumab for the Treatment of Psoriasis.

Published in:

Drugs, 2021, v. 81, n. 15, p. 1751, doi. 10.1007/s40265-021-01612-z

By:

Freitas, Egídio;
Blauvelt, Andrew;
Torres, Tiago

Publication type:

Article

Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies.

Published in:

2021

By:

Valdivielso, José M.;
Balafa, Olga;
Ekart, Robert;
Ferro, Charles J.;
Mallamaci, Francesca;
Mark, Patrick B.;
Rossignol, Patrick;
Sarafidis, Pantelis;
Del Vecchio, Lucia;
Ortiz, Alberto

Publication type:

Correction Notice

Avalglucosidase alfa: First Approval.

Published in:

Drugs, 2021, v. 81, n. 15, p. 1803, doi. 10.1007/s40265-021-01600-3

By:

Dhillon, Sohita

Publication type:

Article

Correction to: Tralokinumab: First Approval.

Published in:

2021

By:

Duggan, Sean

Publication type:

Correction Notice

Correction to: Odevixibat: First Approval.

Published in:

2021

By:

Deeks, Emma D.

Publication type:

Correction Notice

Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders.

Published in:

Drugs, 2021, v. 81, n. 15, p. 1731, doi. 10.1007/s40265-021-01605-y

By:

Akwii, Racheal Grace;
Mikelis, Constantinos M.

Publication type:

Article

Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting.

Published in:

2021

By:

Shirley, Matt

Publication type:

Correction Notice

Anifrolumab: First Approval.

Published in:

Drugs, 2021, v. 81, n. 15, p. 1795, doi. 10.1007/s40265-021-01604-z

By:

Deeks, Emma D.

Publication type:

Article

Correction to: Tralokinumab: First Approval.

Published in:

2021

By:

Duggan, Sean

Publication type:

Correction Notice

REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study.

Published in:

Drugs, 2021, v. 81, n. 15, p. 1763, doi. 10.1007/s40265-021-01597-9

By:

Domingo Ribas, Christian;
Carrillo Díaz, Teresa;
Blanco Aparicio, Marina;
Martínez Moragón, Eva;
Banas Conejero, David;
Sánchez Herrero, M. Guadalupe;
the REDES Study Group;
Muñoz, Mariana;
Cabrerizo, Héctor;
Valero, Antonio;
Arismendi, Ebymar;
Bobolea, Irina;
López, Gemma;
Pinedo, Celia;
González-Barcala, Francisco Javier;
Pérez-López-Corona, Purificación;
Ramos-González, Jacinto;
Martín-Puentes, Javier;
Soto-Campos, Gregorio;
Pérez-Grimaldi, Francisco

Publication type:

Article

Odevixibat: First Approval.

Published in:

Drugs, 2021, v. 81, n. 15, p. 1781, doi. 10.1007/s40265-021-01594-y

By:

Deeks, Emma D.

Publication type:

Article

Furmonertinib: First Approval.

Published in:

Drugs, 2021, v. 81, n. 15, p. 1775, doi. 10.1007/s40265-021-01588-w

By:

Deeks, Emma D.

Publication type:

Article